PCR-based microbiological diagnosis strategy
ProcedureA multiplex PCR-based testing, will be used in addition to standard microbiological culture of the tracheal aspirate to diagnose bacterial pneumonia after inhalation
NCT Number: NCT03763799
The two most common consequences resulting from aspiration are chemical pneumonitis and bacterial aspiration pneumonia. Both entities present with comparable clinical signs and symptoms. In the absence of a reliable clinical or biological marker to differentiate between these two conditions, most patients with suspected aspiration are treated empirically with antibiotics. De-escalation of initial antibiotic treatment is encouraged based on the results of microbiological results, usually performed before starting antimicrobial treatment. However, in most hospitals, 48-72h are required to obtain the results of microbiological cultures, and to de-escalate empirical large spectrum antibiotic treatment.
The use of the Unyvero®, a multiplex PCR-based testing system, for detection of respiratory bacterial pathogens would allow decreasing the percentage of patients with aspiration syndrome who will receive unappropriated antibiotic treatment at Day 3.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Chu Amiens Picardie, Amiens, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
A multiplex PCR-based testing, will be used in addition to standard microbiological culture of the tracheal aspirate to diagnose bacterial pneumonia after inhalation
Standard strategy will be based on with standard microbiological culture of the tracheal aspirate to diagnose bacterial pneumonia after inhalation
Time frame: 48 hours after antibiotic treatment initiation
Time frame: at Day 28 and Day 90 after antibiotic treatment initiation
Time frame: at Day 28 and Day 90 after antibiotic treatment initiation
Time frame: at Day 28 and Day 90 after antibiotic treatment initiation
Time frame: up to Day 90
Time frame: up to Day 90
Time frame: up to Day 90
Time frame: at Day 28 and Day 90 after antibiotic treatment initiation
University Hospital, Lille
Other
Impact of a Strategy Based on the Unyvero® Testing System on Appropriate Antimicrobial Treatment in Patients With Suspected Aspiration Pneumonia Requiring Mechanical Ventilation : a Randomized Controlled Unblinded Trial
Acronym: APAPI
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07508293
Aspiration Pneumonia, Infections
Bursa, Turkey (Türkiye)
View Trial DetailsNCT07382089
Aspiration Pneumonia, Brain Diseases
Addis Ababa, Ethiopia
View Trial DetailsNCT04098224
Aspiration Pneumonia, Infections
Petah Tikva, Isreal, Israel
View Trial DetailsNCT05290844
Aspiration Pneumonia, Cricoid Cartilage
Khobar, Eastern Province, Saudi Arabia
View Trial Details